GSTM1 and sarcopenia: Our study constructed a risk predictive model for sarcopenia in middle-aged and older adult DM patients with good predictive efficacy, which screened 8 predictors, including age, gender, residence, PEF, Hb, DBP, cognitive function, and ADL.